跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROSUVASTATINA/EZETIMIBA SANDOZ 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROSUVASTATINA/EZETIMIBA SANDOZ 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ROSUVASTATINA/EZETIMIBA SANDOZ 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 15, 2022
Approval ID
c12738f233fd8391
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
c12738f233fd8391
Drug Cima Aemps Name
ROSUVASTATINA/EZETIMIBA SANDOZ 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
88392
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2022-12-15
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg/10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
ROSUVASTATINA CALCICA
5,2 mg
EZETIMIBA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 15, 2022
Approval ID
c12738f233fd8391
Type
Standard
Back to CIMA-AEMPS Approvals